Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.
Martin Sebastian WinklerPeter KorstenClaudia BinderBjoern TampePublished in: Annals of the rheumatic diseases (2020)